Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by fredgoodwinsonon Aug 01, 2021 2:55am
427 Views
Post# 33637819

Why the delay?

Why the delay?

What sort of wizardry is this? The Q2 report is supposed to refer to events that took place up until the 30th of June so what are they waiting for?

 

The first of these Quarterlies - through which Shareholders are conditioned Stockholm-syndrome style to slavishly await scraps of information that Management may or may not choose to impart to them on tablets of stone from above - was issued only 10 days` after the end of the Quarter to which it referred but the time it is now taking to issue them is becoming beyond a joke.

 

if anything worthwhile happens after the end of a given Quarter - or for that matter if Roger stubs his toe on a bunsen burner - they are fully entitled to report this via a later separate announcement.The degree to which this additional information can then be contextualised with its` preceding Quarterly will depend upon how clear and well drafted that Quarterly was.

 

To date these Quarterlies have by the woeful nature of their presentation of data left more questions than answers and have as such been effectively useless. Not expecting Q2 2021 - if it is ever published - to represent a break with that tradition.

 

<< Previous
Bullboard Posts
Next >>